Stock listing
A2PLTL Stock Price, News, Filings & Events — Stoke Therapeutics, Inc.
Selected listing: A2PLTL · LSX · EUR · DE
This page tracks Stoke Therapeutics, Inc.'s A2PLTL:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2PLTL:LSX. A2PLTL:LSX is the stock-level entry point for investors researching Stoke Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2PLTL:LSX
- Asset type
- Stock
- Market cap
- $2.04B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSX
- Currency
- EUR
Stoke Therapeutics, Inc. A2PLTL:LSX stock context
This page tracks Stoke Therapeutics, Inc.'s A2PLTL:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2PLTL:LSX. A2PLTL:LSX is the stock-level entry point for investors researching Stoke Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Stoke Therapeutics, Inc.
Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the T...
September 1, 2026
Stoke Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference
August 5, 2026
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Second Quarter 2026 Business and Financial Updates
July 27, 2026
Stoke Therapeutics Appoints Thomas McCauley, Ph.D., as Chief Scientific Officer
July 13, 2026
Stoke Therapeutics Announces Completion of Enrollment of 162 Patients Into the Phase 3 EMPEROR Study of Zorevunersen, an Investigational ...
June 30, 2026
Stoke Therapeutics, Inc. earnings calls
Stoke Therapeutics, Inc. (STOK) Q2 2026 Earnings Call
August 3, 2026 · Replay with transcript and chapters
Stoke Therapeutics, Inc. (STOK) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Stoke Therapeutics, Inc. (STOK) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
Stoke Therapeutics, Inc. (STOK) Q2 2025 Earnings Call
August 12, 2025 · Replay with transcript and chapters
Stoke Therapeutics, Inc. (STOK) Q3 2022 Earnings Call
November 14, 2022 · Replay with transcript and chapters
Research Stoke Therapeutics, Inc.
Stoke Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for A2PLTL:LSX.
Stoke Therapeutics, Inc. company profile
View the public company page for Stoke Therapeutics, Inc. on 6ix.
Stoke Therapeutics, Inc. news
Read company news and market updates connected to Stoke Therapeutics, Inc..
Stoke Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Stoke Therapeutics, Inc..
Alternate listings
STOK:NASDAQ
US · USD
Alternate listing for Stoke Therapeutics, Inc.; the primary context on this page is A2PLTL:LSX.
0GT:GETTEX
DE · EUR
Alternate listing for Stoke Therapeutics, Inc.; the primary context on this page is A2PLTL:LSX.
A2PLTL:LS
DE · EUR
Alternate listing for Stoke Therapeutics, Inc.; the primary context on this page is A2PLTL:LSX.
STOK:BOATS
US · USD
Alternate listing for Stoke Therapeutics, Inc.; the primary context on this page is A2PLTL:LSX.
0GT:FWB
DE · EUR
Alternate listing for Stoke Therapeutics, Inc.; the primary context on this page is A2PLTL:LSX.
0GT:TRADEGATE
DE · EUR
Alternate listing for Stoke Therapeutics, Inc.; the primary context on this page is A2PLTL:LSX.
0GT:DUS
DE · EUR
Alternate listing for Stoke Therapeutics, Inc.; the primary context on this page is A2PLTL:LSX.
0GT:MUN
DE · EUR
Alternate listing for Stoke Therapeutics, Inc.; the primary context on this page is A2PLTL:LSX.
0GT:SWB
DE · EUR
Alternate listing for Stoke Therapeutics, Inc.; the primary context on this page is A2PLTL:LSX.